Company Management (3)
 
BIOSPECTIVE INC.
BIOTECHGATE BY VENTURE VALUATION
Latest up-date: 24 Mar 2014
GENERAL INFORMATION
G
P
T
F
M
D
 
6100 avenue Royalmount
H4P 2R2 Montreal
Canada, Quebec
Contact person Dr. Barry Bedell, COO and CSO
Company main phone +1 (514) 283 2667
Company main fax +1 (514) 221 4471
E-mail [available with subscription]
Website www.biospective.com/
Founded (year) 2000
Source of foundation Independent foundation
   
Corporate description / mission
Biospective is a leading Contract Research Organization (CRO) specializing in animal & human imaging and histopathology services. Biospective’s multi-disciplinary team of experts utilizes its state-of-the-art PIANO, NIGHTWING and PERMITS technologies for quantitative image analysis, including structural MRI measures (brain, hippocampus, and ventricle volumes; cortical thickness), functional MRI measures (ASL perfusion, resting-state BOLD), and PET measures (FDG, amyloid imaging) to evaluate the efficacy of therapeutic agents for Alzheimer’s disease in both animal models and humans.
State of ownership Private / independent
Headquarters Yes
CATEGORIZATION
G
P
T
F
M
D
 
Main sector Biotechnology / R&D Services
Subsector(s)
  • Analytical services
  • CRO (Contract Research Organization)
  • Screening
Primary therapeutic area(s)
  • Diseases of the nervous system
 
Business model
  • Research on contract basis
  • Service company
Customer segments
  • Large biotech & big pharma
  • Small biotech
SUMMARY PRODUCTS / SERVICES / TECHNOLOGIES
G
P
T
F
M
D
 
Description of products
Pre-clinical Services include:
• Imaging Services
• Histology & IHC
• PERMITS

Clinical Services Include:
• Design of image acquisition protocols
• Preparation of independent review charters
• Site qualification and management
• Data management
• State-of-the-art image processing and quantitative analysis
• PET biodistribution studies
• CNS efficacy studies (Alzheimer's disease, multiple
sclerosis, neuropsychiatric disease)
• Oncology efficacy studies.
KEY
G
General profile
P
Products
T
Technologies
F
Financing rounds
M
Management
D
Deals
 
 
Click here to update this profile >>
© 2014 Venture Valuation  |  Impressum  |  Terms of Use & Privacy Policy  |  Print